论文部分内容阅读
Ｅｘｉｓｕｌｉｎｄ是一种选择性诱导凋亡的抗肿瘤药物 ,能通过选择性诱导调亡而显著抑制肿瘤细胞在体外或动物模型体内的生长 ,且不影响正常细胞。Ｅｘｉｓｕｌｉｎｄ被证实有广泛的抗肿瘤谱 ,对包括雄激素敏感与非敏感前列腺癌在内的 5 0种以上的肿瘤细胞系有作用。 96例前列
Exisulind is an anti-tumor drug that selectively induces apoptosis and significantly inhibits the growth of tumor cells in vitro or in animal models by selectively inducing apoptosis without affecting normal cells. Exisulind has been shown to have a broad spectrum of antitumor effects that affect more than 50 tumor cell lines, including androgen-sensitive and non-responsive prostate cancers. 96 cases of the forefront